Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 22966 | 306 | 24.6 | 52% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1052 | 9585 | CARDIOTOXICITY//ANTHRACYCLINES//DOXORUBICIN |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | METHOXYMORPHOLINO DOXORUBICIN | Author keyword | 6 | 100% | 1% | 4 |
| 2 | AD 198 | Author keyword | 4 | 67% | 1% | 4 |
| 3 | METHOXYMORPHOLINYL DOXORUBICIN | Author keyword | 4 | 75% | 1% | 3 |
| 4 | MORPHOLINYLANTHRACYCLINES | Author keyword | 3 | 100% | 1% | 3 |
| 5 | KRN8602 | Author keyword | 2 | 67% | 1% | 2 |
| 6 | NEMORUBICIN | Author keyword | 2 | 67% | 1% | 2 |
| 7 | ANNAMYCIN | Author keyword | 2 | 50% | 1% | 3 |
| 8 | ANTHRACYCLINE ANALOGS | Author keyword | 1 | 100% | 1% | 2 |
| 9 | KRN8602 MX2 | Author keyword | 1 | 100% | 1% | 2 |
| 10 | METHOXYMORPHOLINODOXORUBICIN | Author keyword | 1 | 100% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | METHOXYMORPHOLINO DOXORUBICIN | 6 | 100% | 1% | 4 | Search METHOXYMORPHOLINO+DOXORUBICIN | Search METHOXYMORPHOLINO+DOXORUBICIN |
| 2 | AD 198 | 4 | 67% | 1% | 4 | Search AD+198 | Search AD+198 |
| 3 | METHOXYMORPHOLINYL DOXORUBICIN | 4 | 75% | 1% | 3 | Search METHOXYMORPHOLINYL+DOXORUBICIN | Search METHOXYMORPHOLINYL+DOXORUBICIN |
| 4 | MORPHOLINYLANTHRACYCLINES | 3 | 100% | 1% | 3 | Search MORPHOLINYLANTHRACYCLINES | Search MORPHOLINYLANTHRACYCLINES |
| 5 | KRN8602 | 2 | 67% | 1% | 2 | Search KRN8602 | Search KRN8602 |
| 6 | NEMORUBICIN | 2 | 67% | 1% | 2 | Search NEMORUBICIN | Search NEMORUBICIN |
| 7 | ANNAMYCIN | 2 | 50% | 1% | 3 | Search ANNAMYCIN | Search ANNAMYCIN |
| 8 | ANTHRACYCLINE ANALOGS | 1 | 100% | 1% | 2 | Search ANTHRACYCLINE+ANALOGS | Search ANTHRACYCLINE+ANALOGS |
| 9 | KRN8602 MX2 | 1 | 100% | 1% | 2 | Search KRN8602+MX2 | Search KRN8602+MX2 |
| 10 | METHOXYMORPHOLINODOXORUBICIN | 1 | 100% | 1% | 2 | Search METHOXYMORPHOLINODOXORUBICIN | Search METHOXYMORPHOLINODOXORUBICIN |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MORPHOLINYL ANTHRACYCLINES | 18 | 58% | 7% | 21 |
| 2 | MORPHOLINO ANTHRACYCLINE | 13 | 69% | 4% | 11 |
| 3 | N TRIFLUOROACETYLADRIAMYCIN 14 VALERATE AD 32 | 6 | 71% | 2% | 5 |
| 4 | FCE 23762 | 6 | 58% | 2% | 7 |
| 5 | N BENZYLADRIAMYCIN 14 VALERATE | 6 | 100% | 1% | 4 |
| 6 | RESISTANT HUMAN | 5 | 63% | 2% | 5 |
| 7 | MX2 | 4 | 40% | 3% | 8 |
| 8 | KRN8602 | 3 | 100% | 1% | 3 |
| 9 | PNU 152243 | 3 | 100% | 1% | 3 |
| 10 | METHOXYMORPHOLINYL DOXORUBICIN | 3 | 50% | 1% | 4 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Nemorubicin | 2008 | 1 | 24 | 88% |
| Anthracycline drug targeting: cytoplasmic versus nuclear - a fork in the road | 2001 | 49 | 84 | 12% |
| NOVEL ANTHRACYCLINE ANALOGS | 1990 | 34 | 12 | 33% |
| SYNTHESIS AND STUDY OF STRUCTURE-ACTIVITY-RELATIONSHIPS OF NEW CLASSES OF ANTHRACYCLINES | 1995 | 3 | 11 | 55% |
| SYNTHESIS AND ANTITUMOR-ACTIVITY OF NEW DERIVATIVES OF ANTHRACYCLINE ANTIBIOTICS MODIFIED IN THE SUGAR MOIETY | 1992 | 2 | 43 | 47% |
| Advances in biopharmaceutical analysis in the People's Republic of China: 1993-1995 | 1996 | 1 | 9 | 33% |
| INTRAGENOMIC HETEROGENEITY OF DNA-DAMAGE FORMATION AND REPAIR - A REVIEW OF CELLULAR-RESPONSES TO COVALENT DRUG-DNA INTERACTION | 1994 | 13 | 171 | 12% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MD ANDERSON CANC CLIN INVEST | 1 | 33% | 0.7% | 2 |
| 2 | IMMUNOBIOL DRUG CARRIERS | 1 | 50% | 0.3% | 1 |
| 3 | UT CANC | 0 | 33% | 0.3% | 1 |
| 4 | DEV CANC THER EUT | 0 | 14% | 0.7% | 2 |
| 5 | ANTI CANC DRUG | 0 | 12% | 0.7% | 2 |
| 6 | UMR 176 CNRS | 0 | 10% | 0.7% | 2 |
| 7 | GLOBAL METAB INVEST SCI | 0 | 17% | 0.3% | 1 |
| 8 | UNITA OPERAT 10 | 0 | 13% | 0.3% | 1 |
| 9 | CELLULAIRE MOL PHARMACOL | 0 | 100% | 0.3% | 1 |
| 10 | HIGH MOL WEIGHT COMPOUNDS | 0 | 100% | 0.3% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000276119 | AN 9//SABARUBICIN//AN 7 |
| 2 | 0.0000240851 | MODIFIED ANTIBIOT//IDARUBICINOL//IDARUBICIN |
| 3 | 0.0000206650 | ANTHRACYCLINONE//NISHI OHNUMA//441 NISHI OHNUMA |
| 4 | 0.0000134813 | MENOGARIL//ACLARUBICIN//BIOSYNTHESIS AND PROCESSING |
| 5 | 0.0000109782 | GLUTATHIONE DOXORUBICIN CONJUGATE//RAT HEPATOMA CELL//SIMULTANEOUS IMMOBILIZATION |
| 6 | 0.0000106694 | ERYTHROID GENES//THERMOBIOL//ACLARUBICIN |
| 7 | 0.0000080577 | 2 OXAZOLIDINONE DERIVATIVES//ALFUZOSIN HCL//DIGNOSIS |
| 8 | 0.0000077406 | WATER TARGET//CIDG//O 18H2O |
| 9 | 0.0000075902 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//PSC 833 |
| 10 | 0.0000070580 | CARDIOTOXICITY//DEXRAZOXANE//DOXORUBICIN |